Aurinia shareholders elect all five director nominees and approve auditor and say-on-pay at 2026 AGM

Aurinia Pharmaceuticals Inc.

Five directors elected: Kevin Tang (96.59%), Jeffrey Bailey (95.33%), Kathy Goetz (96.52%), Craig Johnson (86.50%), Tina S. Nova (86.89%).
PricewaterhouseCoopers LLP ratified as independent auditor with 89.14% votes for.
Say-on-pay advisory resolution approved with 93.10% for, 6.05% against, 0.85% abstain.

item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aurinia Pharmaceuticals Inc. shareholders approved Election of Directors at the 2026-06-03 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 1: Based upon the following votes, the shareholders elected Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova to serve as members of the Corporation's board of directors until the annual general meeting of shareholders to be held in 2027. Number of Shares Percentage of Votes Cast Nominee For Withheld Broker Non-Votes For Against Withheld/Abstain Kevin Tang 68,889,411 2,434,090 16,049,984 96.59% 0.00% 3.41% Jeffrey Bailey 67,990,723 3,332,778 16,049,984 95.33% 0.00% 4.67% Kathy Goetz 68,840,807 2,482,694 16,049,984 96.52% 0.00% 3.48% Craig Johnson 61,694,786 9,628,715 16,049,984 86.50% 0.00% 13.50% Tina S. Nova 61,972,942 9,350,560 16,049,983 86.89% 0.00% 13.11%

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aurinia Pharmaceuticals Inc. shareholders approved Non-binding advisory say on pay resolution regarding executive compensation at the 2026-06-03 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a “say on pay” resolution regarding the Corporation's executive compensation. Number of Shares Percentage of Votes Cast For Against Abstain Broker Non-Votes For Against Withheld/Abstain 66,398,971 4,315,143 609,384 16,049,987 93.10% 6.05% 0.85%

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aurinia Pharmaceuticals Inc. shareholders approved Appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-03 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-03

Exact text from the filing

Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2027 or until a successor is appointed. Number of Shares Percentage of Votes Cast For Withhold Broker Non-Votes For Against Withheld/Abstain 77,785,132 9,488,350 3 89.14% 0.00% 10.86%

View on SEC.gov

1591 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Aurinia Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001600620-26-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.